Regenxbio

RGNX • NASDAQ • Stock Fundamentals

Regenxbio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Curran Simpson, with a market cap of $362.4M.

Market Cap$362.4M

Employees344.0

CEOCurran Simpson

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 29 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Regenxbio

Regenxbio (RGNX) has a market capitalization of $362.4M and trades on NASDAQ.

Regenxbio has approximately 344 employees.